1. Home
  2. AAPG vs AVPT Comparison

AAPG vs AVPT Comparison

Compare AAPG & AVPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • AVPT
  • Stock Information
  • Founded
  • AAPG 2009
  • AVPT 2001
  • Country
  • AAPG China
  • AVPT United States
  • Employees
  • AAPG N/A
  • AVPT N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • AVPT Computer Software: Prepackaged Software
  • Sector
  • AAPG Health Care
  • AVPT Technology
  • Exchange
  • AAPG Nasdaq
  • AVPT Nasdaq
  • Market Cap
  • AAPG 3.6B
  • AVPT 3.8B
  • IPO Year
  • AAPG 2025
  • AVPT N/A
  • Fundamental
  • Price
  • AAPG $32.48
  • AVPT $12.77
  • Analyst Decision
  • AAPG Strong Buy
  • AVPT Buy
  • Analyst Count
  • AAPG 3
  • AVPT 8
  • Target Price
  • AAPG $49.00
  • AVPT $18.38
  • AVG Volume (30 Days)
  • AAPG 7.7K
  • AVPT 1.5M
  • Earning Date
  • AAPG 11-19-2025
  • AVPT 11-06-2025
  • Dividend Yield
  • AAPG N/A
  • AVPT N/A
  • EPS Growth
  • AAPG N/A
  • AVPT N/A
  • EPS
  • AAPG N/A
  • AVPT 0.01
  • Revenue
  • AAPG $54,524,554.00
  • AVPT $393,993,000.00
  • Revenue This Year
  • AAPG N/A
  • AVPT $26.20
  • Revenue Next Year
  • AAPG $368.64
  • AVPT $18.17
  • P/E Ratio
  • AAPG N/A
  • AVPT $1,621.28
  • Revenue Growth
  • AAPG N/A
  • AVPT 24.71
  • 52 Week Low
  • AAPG $16.50
  • AVPT $11.49
  • 52 Week High
  • AAPG $48.45
  • AVPT $20.25
  • Technical
  • Relative Strength Index (RSI)
  • AAPG 39.03
  • AVPT 37.14
  • Support Level
  • AAPG $30.93
  • AVPT $12.81
  • Resistance Level
  • AAPG $34.50
  • AVPT $13.33
  • Average True Range (ATR)
  • AAPG 1.00
  • AVPT 0.54
  • MACD
  • AAPG 0.17
  • AVPT -0.04
  • Stochastic Oscillator
  • AAPG 56.90
  • AVPT 42.77

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About AVPT AvePoint Inc.

AvePoint Inc provides customizable solutions to optimize SaaS operations, enable secure collaboration, and accelerate digital transformation across technologies and industries. Its Confidence Platform delivers a comprehensive set of cloud-based solutions enabling IT operations, development operations, and cybersecurity professionals to monitor and secure the digital workplace using SaaS tools.

Share on Social Networks: